Serum and Saliva Level of miR-31-5p and miR-let 7a in EBV Associated Oropharyngeal Cancer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511965 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Polz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Synevo Poland, 80-180 Gdańsk, Poland. Hauptthemen laut MEDLINE: MicroRNAs, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
Epstein-Barr virus (EBV) has a well-documented association with head and neck neoplasms, including nasopharyngeal carcinoma (NPC). In the last few years, research aimed at elucidating the role of the miRs in the pathogenesis of head and neck cancer (HNC) has gained importance. The study of miRs expression has set new directions in the search for biomarkers with diagnostic and prognostic value, and even in the search for new therapeutic targets for various tumors, including HNC. The aim of current study was to approximate the importance of miR-31-5p and miR-let 7a in the pathogenesis of EBV associated oropharyngeal cancer. For this purpose, experiments were carried out to determine the level of mentioned miRs in serum among patients diagnosed with oropharyngeal cancer linked to EBV infection, depending on histological differentiation-grading (G1–G3) and TNM classification. All clinical specimens stratified by HPV status were HPV negative. The level of antibodies EBNA and EBVCA was also assessed. The obtained results showed a significantly increased serum level of miR-31-5p but decreased level of miR-let 7a in EBV positive oropharyngeal cancer patients. We demonstrated association between the level of tested miRs and clinical stage. Our findings showed that miR-31-5p and miR-let-7a may be involved in development and progression of EBV associated oropharyngeal cancer. Therefore, it seems important to further study these molecules, as well as to determine whether they could be important biomarkers in the diagnosis of oropharyngeal cancer associated with EBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Synevo Poland, 80-180 Gdańsk, Poland.
- Department of Otolaryngology Head and Neck Cancer, University of Technology and Humanities in Radom, 26-600 Radom, Poland.
- Department of Radiation Oncology, Oncology Center of Radom, 26-600 Radom, Poland.
- Department of Computer Science and Medical Statistics with the e-Health Laboratory, 20-090 Lublin, Poland.
- 1st Department of Medical Radiology, Medical University of Lublin, 20-093 Lublin, Poland.
- Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.
ORCID-Profile: Kamal Morshed, Małgorzata Polz-Dacewicz
Förderung
- Medical University of Lublin
Zitieren
APA
Polz, A., Morshed, K., Bibik, R., Drop, B., Drop, A., & Polz-Dacewicz, M. (2023). Serum and Saliva Level of miR-31-5p and miR-let 7a in EBV Associated Oropharyngeal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511965
Vancouver
Polz A, Morshed K, Bibik R, Drop B, Drop A, Polz-Dacewicz M. Serum and Saliva Level of miR-31-5p and miR-let 7a in EBV Associated Oropharyngeal Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511965
BibTeX
@article{Polz2023,
author = {Polz, Anna and Morshed, Kamal and Bibik, Robert and Drop, Bartłomiej and Drop, Andrzej and Polz-Dacewicz, Małgorzata},
title = {Serum and Saliva Level of miR-31-5p and miR-let 7a in EBV Associated Oropharyngeal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511965}
}
EUVIMED